Together, Phd2 deficiency in hematopoietic cells (including TAMs), but importantly not in IECs, promotes CAC tumor growth at least in part by activation of the STAT3 and ERK1/2 signaling pathways mediated by EREG. The gene discussed is EGLN1; the disease is neoplasm.